Condensed Consolidating Financial Information - CASH FLOWS (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended |
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 |
Cash Flows from Operating Activities | | | | |
Net (Loss)/Income | $ (48) | $ 163 | $ 281 | $ (682) |
Loss from discontinued operations | (354) | (22) | (320) | (798) |
Net income | 306 | 185 | 601 | 116 |
Adjustments to reconcile net income to net cash provided/(used) by operating activities: | | | | |
Distributions and equity in earnings of unconsolidated affiliates | | | 10 | 0 |
Depreciation, amortization and accretion | | | 403 | 490 |
Provision for bad debts | | | 57 | 57 |
Amortization of nuclear fuel | | | 38 | 37 |
Amortization of financing costs and debt discount/premiums | | | 21 | 15 |
Adjustment for debt extinguishment | | | 22 | 3 |
Amortization of intangibles and out-of-market contracts | | | 21 | 79 |
Amortization of unearned equity compensation | | | 36 | 27 |
Impairment losses | | | 89 | 60 |
Changes in deferred income taxes and liability for uncertain tax benefits | | | (6) | (1) |
Changes in nuclear decommissioning trust liability | | | 50 | 20 |
Changes in derivative instruments | | | (17) | 36 |
Changes in collateral deposits in support of energy risk management activities | | | (30) | (103) |
Gain on sale of emission allowances | | | (20) | 21 |
Gain on sale of assets | (14) | | (30) | (4) |
GenOn settlement in July 2018 | | | (125) | 0 |
Loss on deconsolidation of business | | | 13 | 0 |
Changes in other working capital | | | (375) | (295) |
Cash provided/(used) by continuing operations | | | 758 | 558 |
Cash provided by discontinued operations | | | 324 | 178 |
Net Cash Provided/(Used) by Operating Activities | | | 1,082 | 736 |
Cash Flows from Investing Activities | | | | |
Intercompany dividends | | | | 0 |
Acquisitions of businesses, net of cash acquired | | | (209) | (12) |
Capital expenditures | | | (345) | (172) |
Purchases of emission allowances | | | (30) | (47) |
Proceeds from sale of emission allowances | | | 54 | 104 |
Investments in nuclear decommissioning trust fund securities | | | (449) | (402) |
Proceeds from the sale of nuclear decommissioning trust fund securities | | | 398 | 382 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | | | 1,555 | 309 |
Deconsolidation of business | | | (268) | 0 |
Change in investments in unconsolidated affiliates | | | (62) | 24 |
Other | | | 0 | 30 |
Cash (used)/provided by continuing operations | | | 644 | 216 |
Cash used by discontinued operations | | | (703) | (638) |
Net Cash (Used)/Provided by Investing Activities | | | (59) | (422) |
Cash Flows from Financing Activities | | | | |
Payments (for)/from intercompany loans | | | 0 | 0 |
Intercompany dividends | | | | 0 |
Payment of dividends to common stockholders | | | (28) | (28) |
Payment for treasury stock | | | (1,000) | 0 |
Net receipts from settlement of acquired derivatives that include financing elements | | | | 0 |
Proceeds from issuance of long-term debt | | | 995 | 308 |
Payments for short and long-term debt | | | (970) | (343) |
Increase in notes receivable from affiliate | | | (26) | (125) |
Net distributions to noncontrolling interests in subsidiaries | | | (17) | (18) |
Payment of debt issuance costs | | | (19) | (39) |
Other | | | (4) | (8) |
Cash provided/(used) by continuing operations | | | (1,069) | (253) |
Cash provided by discontinued operations | | | 403 | 39 |
Net Cash Provided/(Used) by Financing Activities | | | (666) | (214) |
Effect of exchange rate changes on cash and cash equivalents | | | 1 | (10) |
Change in Cash from discontinued operations | | | 24 | (421) |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | | | 334 | 511 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | | | 1,083 | 860 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | 1,417 | 1,371 | 1,417 | 1,371 |
Eliminations | | | | |
Cash Flows from Operating Activities | | | | |
Net (Loss)/Income | (399) | (500) | (1,095) | (827) |
Loss from discontinued operations | 0 | 0 | 0 | 0 |
Net income | (399) | (500) | (1,095) | (827) |
Adjustments to reconcile net income to net cash provided/(used) by operating activities: | | | | |
Distributions and equity in earnings of unconsolidated affiliates | | | 0 | 62 |
Depreciation, amortization and accretion | | | 0 | 0 |
Provision for bad debts | | | 0 | 0 |
Amortization of nuclear fuel | | | 0 | 0 |
Amortization of financing costs and debt discount/premiums | | | 0 | 0 |
Adjustment for debt extinguishment | | | 0 | 0 |
Amortization of intangibles and out-of-market contracts | | | 0 | 0 |
Amortization of unearned equity compensation | | | 0 | 0 |
Impairment losses | | | 0 | 0 |
Changes in deferred income taxes and liability for uncertain tax benefits | | | 0 | 0 |
Changes in nuclear decommissioning trust liability | | | 0 | 0 |
Changes in derivative instruments | | | (15) | (8) |
Changes in collateral deposits in support of energy risk management activities | | | 0 | 0 |
Gain on sale of emission allowances | | | 0 | 0 |
Gain on sale of assets | | | 0 | 0 |
GenOn settlement in July 2018 | | | 0 | |
Loss on deconsolidation of business | | | 0 | |
Changes in other working capital | | | 1,110 | 773 |
Cash provided/(used) by continuing operations | | | 0 | 0 |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Operating Activities | | | 0 | 0 |
Cash Flows from Investing Activities | | | | |
Intercompany dividends | | | | (129) |
Acquisitions of businesses, net of cash acquired | | | 0 | 0 |
Capital expenditures | | | 0 | 0 |
Purchases of emission allowances | | | 0 | 0 |
Proceeds from sale of emission allowances | | | 0 | 0 |
Investments in nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from the sale of nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | | | 0 | 0 |
Deconsolidation of business | | | 0 | |
Change in investments in unconsolidated affiliates | | | 0 | 0 |
Other | | | | 0 |
Cash (used)/provided by continuing operations | | | 0 | (129) |
Cash used by discontinued operations | | | | 0 |
Net Cash (Used)/Provided by Investing Activities | | | 0 | (129) |
Cash Flows from Financing Activities | | | | |
Payments (for)/from intercompany loans | | | 0 | 0 |
Intercompany dividends | | | | 129 |
Payment of dividends to common stockholders | | | 0 | 0 |
Payment for treasury stock | | | 0 | |
Net receipts from settlement of acquired derivatives that include financing elements | | | | 0 |
Proceeds from issuance of long-term debt | | | 0 | 0 |
Payments for short and long-term debt | | | 0 | 0 |
Increase in notes receivable from affiliate | | | | 0 |
Net distributions to noncontrolling interests in subsidiaries | | | 0 | 0 |
Payment of debt issuance costs | | | 0 | 0 |
Other | | | 0 | 0 |
Cash provided/(used) by continuing operations | | | 0 | 129 |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Financing Activities | | | 0 | 129 |
Effect of exchange rate changes on cash and cash equivalents | | | 0 | 0 |
Change in Cash from discontinued operations | | | 0 | 0 |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | | | 0 | 0 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | | | 0 | 0 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | 0 | 0 | 0 | 0 |
Guarantor Subsidiaries | | | | |
Cash Flows from Operating Activities | | | | |
Net (Loss)/Income | 306 | 342 | 849 | 737 |
Loss from discontinued operations | 0 | 0 | 0 | 0 |
Net income | 306 | 342 | 849 | 737 |
Adjustments to reconcile net income to net cash provided/(used) by operating activities: | | | | |
Distributions and equity in earnings of unconsolidated affiliates | | | 0 | 0 |
Depreciation, amortization and accretion | | | 240 | 299 |
Provision for bad debts | | | 55 | 42 |
Amortization of nuclear fuel | | | 38 | 37 |
Amortization of financing costs and debt discount/premiums | | | 0 | 0 |
Adjustment for debt extinguishment | | | 0 | 0 |
Amortization of intangibles and out-of-market contracts | | | 15 | 20 |
Amortization of unearned equity compensation | | | 0 | 0 |
Impairment losses | | | 0 | 42 |
Changes in deferred income taxes and liability for uncertain tax benefits | | | 343 | 0 |
Changes in nuclear decommissioning trust liability | | | 50 | 20 |
Changes in derivative instruments | | | (38) | (11) |
Changes in collateral deposits in support of energy risk management activities | | | (16) | (126) |
Gain on sale of emission allowances | | | (20) | 21 |
Gain on sale of assets | | | (3) | (4) |
GenOn settlement in July 2018 | | | 0 | |
Loss on deconsolidation of business | | | 0 | |
Changes in other working capital | | | (567) | (1,035) |
Cash provided/(used) by continuing operations | | | 946 | 42 |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Operating Activities | | | 946 | 42 |
Cash Flows from Investing Activities | | | | |
Intercompany dividends | | | | 0 |
Acquisitions of businesses, net of cash acquired | | | (2) | 0 |
Capital expenditures | | | (158) | (135) |
Purchases of emission allowances | | | (30) | (47) |
Proceeds from sale of emission allowances | | | 54 | 105 |
Investments in nuclear decommissioning trust fund securities | | | (449) | (402) |
Proceeds from the sale of nuclear decommissioning trust fund securities | | | 398 | 382 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | | | 10 | 36 |
Deconsolidation of business | | | 0 | |
Change in investments in unconsolidated affiliates | | | 0 | 0 |
Other | | | | 30 |
Cash (used)/provided by continuing operations | | | (177) | (31) |
Cash used by discontinued operations | | | 0 | 0 |
Net Cash (Used)/Provided by Investing Activities | | | (177) | (31) |
Cash Flows from Financing Activities | | | | |
Payments (for)/from intercompany loans | | | (645) | 9 |
Intercompany dividends | | | | 0 |
Payment of dividends to common stockholders | | | 0 | 0 |
Payment for treasury stock | | | 0 | |
Net receipts from settlement of acquired derivatives that include financing elements | | | | 0 |
Proceeds from issuance of long-term debt | | | 0 | 0 |
Payments for short and long-term debt | | | 0 | 0 |
Increase in notes receivable from affiliate | | | 0 | 0 |
Net distributions to noncontrolling interests in subsidiaries | | | 0 | 0 |
Payment of debt issuance costs | | | 0 | 0 |
Other | | | 0 | 0 |
Cash provided/(used) by continuing operations | | | (645) | 9 |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Financing Activities | | | (645) | 9 |
Effect of exchange rate changes on cash and cash equivalents | | | 0 | 0 |
Change in Cash from discontinued operations | | | 0 | 0 |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | | | 124 | 20 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | | | 41 | 3 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | 165 | 23 | 165 | 23 |
Non-Guarantor Subsidiaries | | | | |
Cash Flows from Operating Activities | | | | |
Net (Loss)/Income | 105 | 121 | 140 | (28) |
Loss from discontinued operations | 17 | 12 | 77 | (134) |
Net income | 88 | 109 | 63 | 106 |
Adjustments to reconcile net income to net cash provided/(used) by operating activities: | | | | |
Distributions and equity in earnings of unconsolidated affiliates | | | 9 | (65) |
Depreciation, amortization and accretion | | | 138 | 167 |
Provision for bad debts | | | 2 | 0 |
Amortization of nuclear fuel | | | 0 | 0 |
Amortization of financing costs and debt discount/premiums | | | 5 | 2 |
Adjustment for debt extinguishment | | | 0 | 3 |
Amortization of intangibles and out-of-market contracts | | | 6 | 59 |
Amortization of unearned equity compensation | | | 0 | 0 |
Impairment losses | | | 89 | 18 |
Changes in deferred income taxes and liability for uncertain tax benefits | | | 11 | (7) |
Changes in nuclear decommissioning trust liability | | | 0 | 0 |
Changes in derivative instruments | | | 40 | 43 |
Changes in collateral deposits in support of energy risk management activities | | | (14) | 23 |
Gain on sale of emission allowances | | | 0 | 0 |
Gain on sale of assets | | | (27) | 0 |
GenOn settlement in July 2018 | | | 0 | |
Loss on deconsolidation of business | | | 13 | |
Changes in other working capital | | | (61) | (484) |
Cash provided/(used) by continuing operations | | | 274 | (135) |
Cash provided by discontinued operations | | | 324 | 178 |
Net Cash Provided/(Used) by Operating Activities | | | 598 | 43 |
Cash Flows from Investing Activities | | | | |
Intercompany dividends | | | | 0 |
Acquisitions of businesses, net of cash acquired | | | (207) | (12) |
Capital expenditures | | | (150) | (18) |
Purchases of emission allowances | | | 0 | 0 |
Proceeds from sale of emission allowances | | | 0 | (1) |
Investments in nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from the sale of nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | | | 8 | 0 |
Deconsolidation of business | | | (268) | |
Change in investments in unconsolidated affiliates | | | (62) | 24 |
Other | | | | 0 |
Cash (used)/provided by continuing operations | | | (679) | (7) |
Cash used by discontinued operations | | | (703) | (638) |
Net Cash (Used)/Provided by Investing Activities | | | (1,382) | (645) |
Cash Flows from Financing Activities | | | | |
Payments (for)/from intercompany loans | | | (12) | 417 |
Intercompany dividends | | | | (129) |
Payment of dividends to common stockholders | | | 0 | 0 |
Payment for treasury stock | | | 0 | |
Net receipts from settlement of acquired derivatives that include financing elements | | | | 0 |
Proceeds from issuance of long-term debt | | | 163 | 94 |
Payments for short and long-term debt | | | (106) | (124) |
Increase in notes receivable from affiliate | | | 0 | (125) |
Net distributions to noncontrolling interests in subsidiaries | | | (17) | (18) |
Payment of debt issuance costs | | | 0 | (34) |
Other | | | (4) | (8) |
Cash provided/(used) by continuing operations | | | 24 | 73 |
Cash provided by discontinued operations | | | 403 | 39 |
Net Cash Provided/(Used) by Financing Activities | | | 427 | 112 |
Effect of exchange rate changes on cash and cash equivalents | | | 1 | (10) |
Change in Cash from discontinued operations | | | 24 | (421) |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | | | (380) | (79) |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | | | 399 | 534 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | 19 | 455 | 19 | 455 |
NRG Energy, Inc. (Note Issuer) | | | | |
Cash Flows from Operating Activities | | | | |
Net (Loss)/Income | (60) | 200 | 387 | (564) |
Loss from discontinued operations | (371) | (34) | (397) | (664) |
Net income | 311 | 234 | 784 | 100 |
Adjustments to reconcile net income to net cash provided/(used) by operating activities: | | | | |
Distributions and equity in earnings of unconsolidated affiliates | | | 1 | 3 |
Depreciation, amortization and accretion | | | 25 | 24 |
Provision for bad debts | | | 0 | 15 |
Amortization of nuclear fuel | | | 0 | 0 |
Amortization of financing costs and debt discount/premiums | | | 16 | 13 |
Adjustment for debt extinguishment | | | 22 | 0 |
Amortization of intangibles and out-of-market contracts | | | 0 | 0 |
Amortization of unearned equity compensation | | | 36 | 27 |
Impairment losses | | | 0 | 0 |
Changes in deferred income taxes and liability for uncertain tax benefits | | | (360) | 6 |
Changes in nuclear decommissioning trust liability | | | 0 | 0 |
Changes in derivative instruments | | | (4) | 12 |
Changes in collateral deposits in support of energy risk management activities | | | 0 | 0 |
Gain on sale of emission allowances | | | 0 | 0 |
Gain on sale of assets | | | 0 | 0 |
GenOn settlement in July 2018 | | | (125) | |
Loss on deconsolidation of business | | | 0 | |
Changes in other working capital | | | (857) | 451 |
Cash provided/(used) by continuing operations | | | (462) | 651 |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Operating Activities | | | (462) | 651 |
Cash Flows from Investing Activities | | | | |
Intercompany dividends | | | | 129 |
Acquisitions of businesses, net of cash acquired | | | 0 | 0 |
Capital expenditures | | | (37) | (19) |
Purchases of emission allowances | | | 0 | 0 |
Proceeds from sale of emission allowances | | | 0 | 0 |
Investments in nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from the sale of nuclear decommissioning trust fund securities | | | 0 | 0 |
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees | | | 1,537 | 273 |
Deconsolidation of business | | | 0 | |
Change in investments in unconsolidated affiliates | | | 0 | 0 |
Other | | | | 0 |
Cash (used)/provided by continuing operations | | | 1,500 | 383 |
Cash used by discontinued operations | | | | 0 |
Net Cash (Used)/Provided by Investing Activities | | | 1,500 | 383 |
Cash Flows from Financing Activities | | | | |
Payments (for)/from intercompany loans | | | 657 | (426) |
Intercompany dividends | | | | 0 |
Payment of dividends to common stockholders | | | (28) | (28) |
Payment for treasury stock | | | (1,000) | |
Net receipts from settlement of acquired derivatives that include financing elements | | | | 0 |
Proceeds from issuance of long-term debt | | | 832 | 214 |
Payments for short and long-term debt | | | (864) | (219) |
Increase in notes receivable from affiliate | | | (26) | 0 |
Net distributions to noncontrolling interests in subsidiaries | | | 0 | 0 |
Payment of debt issuance costs | | | (19) | (5) |
Other | | | 0 | 0 |
Cash provided/(used) by continuing operations | | | (448) | (464) |
Cash provided by discontinued operations | | | 0 | 0 |
Net Cash Provided/(Used) by Financing Activities | | | (448) | (464) |
Effect of exchange rate changes on cash and cash equivalents | | | 0 | 0 |
Change in Cash from discontinued operations | | | 0 | 0 |
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | | | 590 | 570 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | | | 643 | 323 |
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | $ 1,233 | $ 893 | $ 1,233 | $ 893 |